RESMED INC — Director's Dealing 2021

Nov 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-11

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-11	ResMed Common Stock	F	1549	$259.47	Disposed	119502	Direct
2021-11-11	ResMed Common Stock	M	983	$101.64	Acquired	120485	Direct
2021-11-11	ResMed Common Stock	G	10000	—	Disposed	110485	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-11	ResMed Common Stock Options	$101.64	M	983	Disposed	2025-11-14	ResMed Common Stock (983)	Direct

Footnotes

F1: Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/14/2018, 11/21/2019 and 11/19/2020.

F2: Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares.

F3: Includes 64.3996 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.

F4: Represents date options first became exercisable. Options vest 1/3 per year.